Recap: Intra-Cellular Therapies Q1 Earnings

Intra-Cellular Therapies ITCI reported its Q1 earnings results on Thursday, May 4, 2023 at 07:30 AM.

Here's what investors need to know about the announcement.

Earnings

Intra-Cellular Therapies beat estimated earnings by 23.33%, reporting an EPS of $-0.46 versus an estimate of $-0.6.

Revenue was up $60.31 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.14 which was followed by a 5.68% drop in the share price the next day.

Here's a look at Intra-Cellular Therapies's past performance:

To track all earnings releases for Intra-Cellular Therapies visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.